NCT03328663

Brief Summary

This research study is evaluating the impact of a psychological intervention on the quality of life and mood of caregivers of patients undergoing stem cell transplant.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable cancer

Timeline
Completed

Started Jan 2018

Longer than P75 for not_applicable cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 29, 2017

Completed
3 days until next milestone

First Posted

Study publicly available on registry

November 1, 2017

Completed
2 months until next milestone

Study Start

First participant enrolled

January 1, 2018

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2019

Completed
5.8 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

March 20, 2026

Completed
Last Updated

March 20, 2026

Status Verified

March 1, 2026

Enrollment Period

1.2 years

First QC Date

October 29, 2017

Results QC Date

February 7, 2026

Last Update Submit

March 1, 2026

Conditions

Keywords

Cancer Care

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the Intervention (Feasibility Description Below)

    Feasibility defined if eligible caregivers randomized to intervention attend at least 50% of the intervention visits

    15 months

Secondary Outcomes (5)

  • Compare Caregiver Quality of Life (QOL) as Measured by the Caregiver Oncology QOL (CarGOQOL) Questionnaire Between the Study Arms

    day 60

  • Compare Caregiving Burden (CRA) Between the Study Arms

    day 60

  • Compare Caregiver Anxiety Using Hospital Anxiety and Depression Scale (HADS) Between the Study Arms

    day 60

  • Compare Caregiver Self-efficacy Using the Cancer Self-Efficacy Scale-Transplant (CASE-t) Between the Study Arms

    day 60

  • Compare Perceived Coping Skills (MOCS) Between the Study Arms

    day 60

Study Arms (2)

CARE intervention

EXPERIMENTAL

* Six psychological intervention sessions in-person or via video conferencing conducted by a trained psychologist * The CARE intervention contain 3 component * a psychoeducational component to address preparednessmanage expectations, and develop caregiving skills * a psychosocial component focusing on coping strategies, mindfulness, and facilitating acceptance while living with uncertainty * a self-care component to promote caregiver health and well-being

Other: CARE

Standard transplant care

ACTIVE COMPARATOR

* Standard Transplant Care * Social work consults to help caregivers only upon request

Other: CAREOther: Standard Transplant Care

Interventions

CAREOTHER

Promote effective coping and reduce caregiving burden.

CARE interventionStandard transplant care

Standard cared administered by the hospital.

Standard transplant care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult caregivers (≥18 years) of patients undergoing autologous or allogeneic HCT at MGH, and they must attend the HCT consent visit with the patient.
  • A relative or a friend who either lives with the patient or has in-person contact with him or her at least twice per week and is identified as the primary caregiver for transplant.
  • Ability to speak English or able to complete questionnaires with minimum assistance of an interpreter.

You may not qualify if:

  • Significant uncontrolled psychiatric or other co-morbid disease, which the primary oncologist believes prohibits the ability to participate in study procedures

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

MeSH Terms

Conditions

Neoplasms

Results Point of Contact

Title
Areej El-Jawahri
Organization
Massachusetts General Hospital

Study Officials

  • Areej El-Jawahri, MD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 29, 2017

First Posted

November 1, 2017

Study Start

January 1, 2018

Primary Completion

April 1, 2019

Study Completion

December 30, 2024

Last Updated

March 20, 2026

Results First Posted

March 20, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Locations